ZA725037B - Improvements relating to cholesterol-decreasing agents - Google Patents
Improvements relating to cholesterol-decreasing agentsInfo
- Publication number
- ZA725037B ZA725037B ZA725037A ZA725037A ZA725037B ZA 725037 B ZA725037 B ZA 725037B ZA 725037 A ZA725037 A ZA 725037A ZA 725037 A ZA725037 A ZA 725037A ZA 725037 B ZA725037 B ZA 725037B
- Authority
- ZA
- South Africa
- Prior art keywords
- cholesterol
- improvements relating
- decreasing agents
- decreasing
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/56—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2136929A DE2136929C3 (en) | 1971-07-23 | 1971-07-23 | Use of certain 3 ', 4'-methylenedioxiphenylpiperazines |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA725037B true ZA725037B (en) | 1974-03-27 |
Family
ID=5814649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA725037A ZA725037B (en) | 1971-07-23 | 1972-07-21 | Improvements relating to cholesterol-decreasing agents |
Country Status (10)
Country | Link |
---|---|
AU (1) | AU469760B2 (en) |
BE (1) | BE786578A (en) |
CA (1) | CA991079A (en) |
DE (1) | DE2136929C3 (en) |
FR (1) | FR2147096B1 (en) |
GB (1) | GB1390806A (en) |
IE (1) | IE36586B1 (en) |
IL (1) | IL39964A (en) |
NL (1) | NL7210147A (en) |
ZA (1) | ZA725037B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684651A (en) * | 1981-03-17 | 1987-08-04 | Mitsubishi Chemical Industries Limited | Alkylenedioxybenzene and acid addition salts thereof useful as hypotensives |
-
0
- BE BE786578D patent/BE786578A/en not_active IP Right Cessation
-
1971
- 1971-07-23 DE DE2136929A patent/DE2136929C3/en not_active Expired
-
1972
- 1972-07-21 IL IL39964A patent/IL39964A/en unknown
- 1972-07-21 CA CA147,644A patent/CA991079A/en not_active Expired
- 1972-07-21 FR FR7226354A patent/FR2147096B1/fr not_active Expired
- 1972-07-21 AU AU44865/72A patent/AU469760B2/en not_active Expired
- 1972-07-21 GB GB3430072A patent/GB1390806A/en not_active Expired
- 1972-07-21 ZA ZA725037A patent/ZA725037B/en unknown
- 1972-07-21 NL NL7210147A patent/NL7210147A/xx not_active Application Discontinuation
- 1972-07-23 IE IE1028/72A patent/IE36586B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE36586B1 (en) | 1976-12-08 |
FR2147096B1 (en) | 1976-03-05 |
AU4486572A (en) | 1974-01-24 |
DE2136929B2 (en) | 1980-02-07 |
DE2136929C3 (en) | 1980-10-02 |
GB1390806A (en) | 1975-04-16 |
NL7210147A (en) | 1973-01-25 |
IL39964A (en) | 1975-08-31 |
IE36586L (en) | 1973-01-23 |
IL39964A0 (en) | 1972-09-28 |
DE2136929A1 (en) | 1973-02-08 |
BE786578A (en) | 1973-01-22 |
CA991079A (en) | 1976-06-15 |
FR2147096A1 (en) | 1973-03-09 |
AU469760B2 (en) | 1976-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE36891L (en) | Coronary-dilating composition | |
AU5119173A (en) | Composition | |
HK47978A (en) | Improvements relating to scaffolding | |
ZA728584B (en) | Improvements relating to containers | |
CY783A (en) | Improvements relating to fastening devices | |
ZA722177B (en) | Improvements relating to sulphamides | |
ZA721072B (en) | Improvements relating to n-(furyl-methyl)-morphinanes | |
ZA721238B (en) | Improvements relating to seats | |
ZA715393B (en) | Improvements relating to azepine-derivatives | |
ZA723457B (en) | Improvements relating to reconstituted-tobaccosmoking materials | |
MY7900109A (en) | Improvements in or relating to thienobenzazepines | |
ZA712788B (en) | Improvements relating to phenylaminoalkanes | |
ZA716643B (en) | Improvements relating to 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes | |
ZA724206B (en) | Improvements relating to crane-head beams | |
ZA72209B (en) | Improvements relating to briefs | |
ZA723068B (en) | Improvements in or relating to wellpoints | |
ZA723840B (en) | Improvements relating to phenylimidazolidinones | |
HK48076A (en) | Improvements relating to pencils | |
ZA725037B (en) | Improvements relating to cholesterol-decreasing agents | |
ZA71225B (en) | Improvements relating to cardenoliderhamnosides | |
ZA722161B (en) | Improvements relating to 4-hydroxy-1-phenyl-2-pyrrolidino-pentane | |
ZA729073B (en) | Improvements relating to benzodiazepines | |
ZA728201B (en) | Improvements relating to castors | |
ZA728281B (en) | Improvements relating to penicillin acylace | |
YU282572A (en) | Kuciste i poklopac kucista |